VMP 42373711000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-tenidone 50mg/12.5mg tablets
BNF code 020400040AAAAAA
Virtual Therapeutic Moiety Co-tenidone
Date identifier became valid 27 Oct 2023
Previous product identifier 318575007
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-tenidone 50/12.5 tablets
Basis of previous name BAN - British Approved Name
Reason for name change
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Atenolol
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Chlortalidone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 12.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-tenidone 50mg/12.5mg tablets (A A H Pharmaceuticals Ltd)
Co-tenidone 50mg/12.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-tenidone 50mg/12.5mg tablets (Almus Pharmaceuticals Ltd)
Co-tenidone 50mg/12.5mg tablets (Medihealth (Northern) Ltd)
Co-tenidone 50mg/12.5mg tablets (Medreich Plc)
Co-tenidone 50mg/12.5mg tablets (Phoenix Healthcare Distribution Ltd)
Co-tenidone 50mg/12.5mg tablets (RX Farma)
Co-tenidone 50mg/12.5mg tablets (Sigma Pharmaceuticals Plc)
Co-tenidone 50mg/12.5mg tablets (Wockhardt UK Ltd)
Tenoret 50mg/12.5mg tablets (Atnahs Pharma UK Ltd)
Virtual Medicinal Product Packs
Co-tenidone 50mg/12.5mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback